Form 8-K - Current report:
SEC Accession No. 0000950170-21-002521
Filing Date
2021-10-29
Accepted
2021-10-29 17:00:44
Documents
12
Period of Report
2021-10-27
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K acet-20211027.htm   iXBRL 8-K 50905
  Complete submission text file 0000950170-21-002521.txt   179397

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20211027.xsd EX-101.SCH 2495
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20211027_pre.xml EX-101.PRE 11504
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20211027_lab.xml EX-101.LAB 19138
5 EXTRACTED XBRL INSTANCE DOCUMENT acet-20211027_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211364070
SIC: 2834 Pharmaceutical Preparations